B K Manne1, P Münzer2, R Badolia3, B Walker-Allgaier2, R A Campbell1, E Middleton1, A S Weyrich1, S P Kunapuli3, O Borst2, M T Rondina1,4. 1. Department of Internal Medicine, Molecular Medicine Program, University of Utah, Salt Lake City, UT, USA. 2. Department of Cardiology and Cardiovascular Medicine, University of Tübingen, Tübingen, Germany. 3. Sol Sherry Thrombosis Research Center, Temple University School of Medicine, Philadelphia, PA. 4. Department of Internal Medicine, GRECC, George E. Wahlen VAMC, Salt Lake City, UT, USA.
Abstract
Essentials Phosphoinositide 3-kinase and MAPK pathways crosstalk via PDK1. PDK1 is required for adenosine diphosphate-induced platelet activation and thromboxane generation. PDK1 regulates RAF proto-oncogene Ser/Thr kinase (Raf1) activation in the MAPK pathway. Genetic ablation of PDK1 protects against platelet-dependent thrombosis in vivo. SUMMARY: Background Platelets are dynamic effector cells with functions that span hemostatic, thrombotic and inflammatory continua. Phosphoinositide-dependent protein kinase 1 (PDK1) regulates protease-activated receptor 4-induced platelet activation and thrombus formation through glycogen synthase kinase3β. However, whether PDK1 also signals through the ADP receptor and its functional importance in vivo remain unknown. Objective To establish the mechanism of PDK1 in ADP-induced platelet activation and thrombosis. Methods We assessed the role of PDK1 on 2MeSADP-induced platelet activation by measuring aggregation, thromboxane generation and phosphorylation events in the presence of BX-795, which inhibits PDK1, or by using platelet-specific PDK1 knockout mice and performing western blot analysis. PDK1 function in thrombus formation was assessed with an in vivo pulmonary embolism model. Results PDK1 inhibition with BX-795 reduced 2-methylthio-ADP (2MeSADP)-induced aggregation of human and murine platelets by abolishing thromboxane generation. Similar results were observed in pdk1-/- mice. PDK1 was also necessary for the phosphorylation of mitogen-activated protein kinase kinase 1/2 (MEK1/2), extracellular signal-regulated kinase 1/2, and cytosolic phospholipase A2, indicating that PDK1 regulates an upstream kinase in the mitogen-activated protein kinase (MAPK) pathway. We next determined that this upstream kinase is Raf-1, a serine/threonine kinase that is necessary for the phosphorylation of MEK1/2, as pharmacological inhibition and genetic ablation of PDK1 were sufficient to prevent Raf1 phosphorylation. Furthermore, in vivo inhibition or genetic ablation of PDK1 protected mice from collagen/epinephrine-induced pulmonary embolism. Conclusion PDK1 governs thromboxane generation and thrombosis in platelets that are stimulated with 2MeSADP by regulating activation of the MAPK pathway.
Essentials Phosphoinositide 3-kinase and MAPK pathways crosstalk via PDK1. PDK1 is required for adenosine diphosphate-induced platelet activation and thromboxane generation. PDK1 regulates RAF proto-oncogene Ser/Thr kinase (Raf1) activation in the MAPK pathway. Genetic ablation of PDK1 protects against platelet-dependent thrombosis in vivo. SUMMARY: Background Platelets are dynamic effector cells with functions that span hemostatic, thrombotic and inflammatory continua. Phosphoinositide-dependent protein kinase 1 (PDK1) regulates protease-activated receptor 4-induced platelet activation and thrombus formation through glycogen synthase kinase3β. However, whether PDK1 also signals through the ADP receptor and its functional importance in vivo remain unknown. Objective To establish the mechanism of PDK1 in ADP-induced platelet activation and thrombosis. Methods We assessed the role of PDK1 on 2MeSADP-induced platelet activation by measuring aggregation, thromboxane generation and phosphorylation events in the presence of BX-795, which inhibits PDK1, or by using platelet-specific PDK1 knockout mice and performing western blot analysis. PDK1 function in thrombus formation was assessed with an in vivo pulmonary embolism model. Results PDK1 inhibition with BX-795 reduced 2-methylthio-ADP (2MeSADP)-induced aggregation of human and murine platelets by abolishing thromboxane generation. Similar results were observed in pdk1-/- mice. PDK1 was also necessary for the phosphorylation of mitogen-activated protein kinase kinase 1/2 (MEK1/2), extracellular signal-regulated kinase 1/2, and cytosolic phospholipase A2, indicating that PDK1 regulates an upstream kinase in the mitogen-activated protein kinase (MAPK) pathway. We next determined that this upstream kinase is Raf-1, a serine/threonine kinase that is necessary for the phosphorylation of MEK1/2, as pharmacological inhibition and genetic ablation of PDK1 were sufficient to prevent Raf1 phosphorylation. Furthermore, in vivo inhibition or genetic ablation of PDK1 protected mice from collagen/epinephrine-induced pulmonary embolism. Conclusion PDK1 governs thromboxane generation and thrombosis in platelets that are stimulated with 2MeSADP by regulating activation of the MAPK pathway.
Authors: Jesse W Rowley; Stéphane Chappaz; Aurélie Corduan; Mark M W Chong; Robert Campbell; Amanda Khoury; Bhanu Kanth Manne; Jeremy G T Wurtzel; James V Michael; Lawrence E Goldfinger; Michele M Mumaw; Marvin T Nieman; Benjamin T Kile; Patrick Provost; Andrew S Weyrich Journal: Blood Date: 2016-01-14 Impact factor: 22.113
Authors: Bhanu Kanth Manne; Seema Bhatlekar; Elizabeth A Middleton; Andrew S Weyrich; Oliver Borst; Matthew T Rondina Journal: J Thromb Haemost Date: 2020-03-05 Impact factor: 5.824
Authors: Seema Bhatlekar; Shancy Jacob; Bhanu K Manne; Li Guo; Frederik Denorme; Emilia A Tugolukova; Mark J Cody; Yasuhiro Kosaka; Isidore Rigoutsos; Robert A Campbell; Jesse W Rowley; Ryan M O'Connell; Paul F Bray Journal: Blood Cells Mol Dis Date: 2021-11-03 Impact factor: 2.372
Authors: Frederik Denorme; Bhanu Kanth Manne; Irina Portier; Alicia S Eustes; Yasuhiro Kosaka; Benjamin T Kile; Matthew T Rondina; Robert A Campbell Journal: Blood Date: 2020-02-06 Impact factor: 25.476
Authors: Bhanu Kanth Manne; Frederik Denorme; Elizabeth A Middleton; Irina Portier; Jesse W Rowley; Chris Stubben; Aaron C Petrey; Neal D Tolley; Li Guo; Mark Cody; Andrew S Weyrich; Christian C Yost; Matthew T Rondina; Robert A Campbell Journal: Blood Date: 2020-09-10 Impact factor: 25.476